Sanofi-Aventis Receives Pediatric Exclusivity For Ambien® And Ambien® CR
Fri, 01 Dec 2006 08:00 AM EST
... Sanofi-aventis announced today that the U.S. Foodand Drug Administration (FDA) has granted pediatric exclusivity for Ambien® (zolpidemtartrate) and Ambien® CR (zolpidem tartrate extended-release). [click link for full article] ...
Related Topics
- Children's Health
- Paroxetine
- Pediatric Care
- Pediatric Aids
- Isradipine Extended-Release Tablets
- Carbidopa and Levodopa SR
- Lithium, Extended-Release
- Autoimmune Disorders
- Disopyramide
- Nifedipine ER
- Didanosine Pediatric Oral Solution
- Carbamazepine
- Potassium Chloride Oral
- Telithromycin
- Insulin glargine
- Myocarditis - pediatric
- Asthma - pediatric
- Pediatric Rheumatology Clinic
- Shapedown Pediatric Obesity
- Pediatric Nutrition Surveillance System

Not Signed In -

